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Summary
Background: Enterococci are pathogens that can cause nosocomial infections
and acquire resistance properties via several molecular mechanisms. The aac
(6′)Ie-aph(2′′)Ia gene plays a signiﬁcant role in the emergence of high-level
gentamicin-resistant (HLGR) strains. The screening of resistant strains and the provi-
sion of appropriate antibiotic therapy can decide the outcome of serious nosocomial
infections.
Methods: In the present study, 142 enterococci were isolated from patients, and
the species were identiﬁed using standard methods. An antimicrobial susceptibility
test was performed using the disc diffusion method, and the minimum inhibition
concentration (MIC) of gentamicin was determined according to the broth micro-
dilution method. Additionally, PCR was utilized to detect the aac(6′)Ie-aph(2′′)Ia
gene, the presence of which was conﬁrmed by digestion with Sca1 and sequencing.
Results: Of the 142 isolates, 62 (43.7%) were found to exhibit the HLGR phenotype.
All except one of the HLGR isolates contained the aac(6′)Ie-aph(2′′)Ia gene. The
prevalence of resistance to other antibiotics and multi-drug resistance (MDR) was
higher among the HLGR isolates compared to the non-HLGR isolates.
Conclusions: Our results indicate that high prevalence rates of MDR and HLGR entero-
cocci are an important problem associated with medical treatment. Furthermore,
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the presence of the aac(6′)Ie-aph(2′′)Ia gene was shown to correspond to the presence
of the HLGR phenotype among enterococci.
dulaziz University for Health Sciences. Published by Elsevier
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and tetracycline (30g), were investigated for
all isolates using the disc diffusion method© 2013 King Saud Bin Ab
Ltd. All rights reserved.
ntroduction
nterococci are Gram-positive microorganisms
ound in the mammalian gut ﬂora, soil, water,
lants, vegetables and foods and are known to
e potent pathogens responsible for nosocomial
nfections [1,2]. This genus contains more than
0 species, of which Enterococcus faecium and
nterococcus faecalis are isolated at a high fre-
uency [3] from hospital-acquired infections,
articularly bacteremia and endocarditis, as well
s the genitourinary and gastrointestinal tracts.
ence, the proper treatment of these cases is an
mportant area of focus [2]. Extensive adminis-
ration and misuse of antimicrobial agents lead
o the emergence of Enterococcus species with
cquired resistance to antibiotics, including high
oncentrations of aminoglycosides, -lactams
nd glycopeptides. These resistance events can
nclude the loss of the synergistic effects of
minoglycoside antibiotics on cell-wall active
omponents. Furthermore, some Enterococcus
pecies intrinsically possess genes that encode
minoglycoside-modifying enzymes (AME). These
enes can be contained within DNA located on
lasmids or chromosomes as well as transposons
4]. In 1979, high-level gentamicin resistance
HLGR) was reported in France for the ﬁrst time
2]. Until recently, the expression of only one
i-functional AME with both 6′-acetyltransferase
nd 2′′-phosphotransferase activities, encoded
y the structural gene aac(6′)Ie-aph(2′′)Ia, had
een described as resulting in the emergence of
LGR in enterococci. However, three new cor-
esponding genes, termed aph(2′′)-Ib, aph(2′′)-Ic
nd aph(2′′)-Id, have also been shown to con-
ribute to gentamicin resistance in enterococci [5].
he spread of resistant species via chromosomal
xchange as well as plasmid and transposon transfer
rom one patient to another can lead to an increase
n dangerous nosocomial infections that are dif-
cult to treat [1]. Therefore, the identiﬁcation
f such resistant strains can be helpful in limiting
erious nosocomial infections. Methods such as
iotyping, antimicrobial susceptibility testing
(
M
d
(nd molecular techniques are effective for this
urpose [6].
In this study, our aim was to identify antibiotic
esistant proﬁles in HLGR and non-HLGR entero-
occi isolated from clinical samples in an Iranian
ospital. Furthermore, we assessed the frequency
f the aac(6′)Ie-aph(2′′)Ia gene in the HLGR group.
aterials and methods
solation and identiﬁcation of bacterial
trains
o isolate enterococcus strains, samples of urine,
lood, wound secretions, body ﬂuids, pulmonary
ecretions and abscess ﬂuids were collected from
atients hospitalized in the Educational Hospi-
al in northern Tehran during a 6 month period
March—September 2009). Pure strains obtained
rom the growth of each sample on blood-agar
lates at 37 ◦C were examined using conventional
ethods to identify the genus and species. To
etermine the genus, Gram staining, catalase test-
ng, growth in the presence of 6.5% NaCl and bile
nd hydrolysis of esculin and PYR (L-pyrolidonyl--
aphthylamidase) were evaluated. In addition, the
pecies type of each isolate was identiﬁed using
iochemical tests, such as the motility test and
rginine hydrolysis. In addition, the sugar fermen-
ation patterns of arabinose, sorbitol, mannitol,
orbose and sucrose were assessed [7].
ntimicrobial susceptibility testing
he antimicrobial susceptibility patterns to seven
ntibiotics, including ampicillin (10g), gentami-
in (120g), vancomycin (30g), chloramphenicol
30g), ciproﬂoxacin (5g), erythromycin (15g)Kirby—Bauer) according to CSLI guidelines (Bootle,
ast Mersey Side, UK). In addition, the micro-
ilution method was used to screen for HLGR strains
MIC≥ 500g/ml). Interpretation of the obtained
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Table 1 Number and percent of HLGR isolates
according to MIC.
Species Concentration (g/ml)
512 ≥1024
E. faecalis 9 (28.1%) 23 (71.9%)
E. faecium 2 (9.5%) 19 (90.5%)
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results and the MIC determination was performed
according to CSLI guidelines (8—1024g/ml) [8].
DNA extraction and PCR ampliﬁcation of the
resistance gene
The presence of the aac(6′)Ie-aph(2′′)Ia gene in
the genome of HLGR isolates was established using
PCR. DNA was extracted according to the method
described by Belanger et al. [9] and was then
ampliﬁed in 20l reaction mixtures containing 10×
reaction buffer, 0.2mM of the deoxynucleoside
triphosphates (dNTPs), 2.5mM MgCl2, 10 pmol of
each of the primers, 100 ng of genomic DNA as
the template and 1.5U of Taq DNA polymerase
(Fermentas). The primers used in this study were
designed by Qu et al. [10]. PCR was performed in
an Eppendorf thermal cycler with an initial dena-
turation step of 4min at 95 ◦C; 32 cycles of 1min
at 95 ◦C, 1min at 55 ◦C and 1min at 72 ◦C; and a
ﬁnal extension step of 5min at 72 ◦C. Then, the
presence of products with a size of 505 bp was
assessed by electrophoresis on a 1% agarose gel
stained with 0.5mg/ml ethidium bromide and visu-
alized under UV illumination. E. faecalis JH22 was
used as a negative control strain. Finally, 3g of
each PCR product was digested with the endonucle-
ase Sca1 (Roche, Germany) to conﬁrm the presence
of this gene. Sca1 is able to cut a position within
the ampliﬁed aac(6′)Ie-aph(2′′)Ia gene. The sizes of
the two created fragments were 242 bp and 263 bp
(VEB Cutter2 software). For further corroboration,
the DNA was sequenced (Macrogen Research, Seoul,
Korea), and the sequenced genes were subjected to
BLAST comparison with the M13771 standard strain;
the sequence homology was 99% as determined
using the MEGA4 software.
Results
Strain isolation
Enterococcal strains were isolated from 142
specimens collected during the study period at fre-
quencies of 63% (90) for E. faecalis, 33% (47) for
E. faecium, 0.7% (1) for Enterococcus gallinarum,
1.4% (2) for Enterococcus casseliﬂavus and 1.4%
(2) for Enterococcus sulitarius. Furthermore, these
strains were isolated from urine, wounds, blood,
body ﬂuid, pulmonary secretions, abscess ﬂuid and
catheter specimens at frequencies of 74% (105),
14% (20), 2.8% (4), 3.5% (5), 3.5% (5), 1.4% (2) and
0.7% (1), respectively.
The HLGR phenotype was detected in 62 (43.7%)
patients. The majority of the HLGR strains were E.
l
E
ME. sulitarius 0 1 (100%)
E. casseliﬂavus 1 (100%) 0
aecalis (38) (61.3%) and E. faecium (21) (33.9%).
he frequency pattern of the HLGR phenotype in
hese specimens is shown in Table 1. The MIC values
or the HLGR isolates were measured in the range
rom 512 to >1024g/ml using the micro-dilution
ethod. MIC levels greater than 500g/ml were
emonstrated in 55 (89%) of the HLGR isolates.
ntimicrobial susceptibility testing
o evaluate the antibiotic resistance status of each
train, we used an antimicrobial susceptibility test.
s illustrated in Fig. 1, the frequencies of resis-
ance to tetracycline and vancomycin were found
o be the highest and lowest, respectively. Fur-
hermore, more than 50% of the isolates showed
esistance to chloramphenicol and ciproﬂoxacin.
he most frequent type of antibiotic resistance
mong the E. faecalis, E. faecium and E. gallinarum
solates was against tetracycline (Fig. 1). All of the
. casseliﬂavus isolates were resistant to chloram-
henicol and ciproﬂoxacin. In addition, with the
xceptions of erythromycin and vancomycin, the E.
ulitarius isolates were resistant to all of antibiotics
xamined in this study.
Of the strains with the HLGR phenotype, more
han 70% of the E. faecalis and E. faecium isolates
ere resistant to erythromycin, tetracycline and
iproﬂoxacin (Table 2). Ampicillin resistance was
etected in 76% of the E. faecium isolates. All of the
. casseliﬂavus and E. sulitarius isolates with the
LGR phenotype were resistant to all antibiotics
xcept vancomycin.
In addition, 45.7% of the isolates that displayed
esistance to more than three antibiotics were
ategorized as multi-drug resistant (MDR). The
ajority of these isolates also belonged to the HLGR
ategory; 31.7% of the HLGR strains and 14% of the
on-HLGR stains were MDR.
In the HLGR group, MDR was observed in 57.8%
f E. faecalis isolates and 70% of E. faecium iso-
ates. Table 3 shows the MDR patterns of the HLGR
. faecalis and E. faecium isolates.
The frequencies of both antibiotic resistance and
DR were higher in HLGR isolates as compared to
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Figure 1 Percentage of enterococcal resistance to several antibiotics. The pattern of antibiotic resistance for each
species is illustrated in this ﬁgure. The total data indicate the percentage of resistance among all of the isolates.
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Figure 3 Gel electrophoresis of aac(6′)Ie-aph(2′′)Ia geneigure 2 Percentage of enterococcal resistance to seve
o the disc diffusion method.
on-HLGR isolates (Fig. 2) as well among E. faecium
solates as compared to E. faecalis isolates.
All of the 11 (7.7%) E. faecium vancomycin-
esistant isolates were also resistant to ampicillin,
rythromycin and ciproﬂoxacin.
CR and sequencing results
′nly 1 of 62 HLGR isolates lacked the aac(6 )-
ph(2′′) gene. Figs. 3 and 4 show an example
f a PCR product obtained from an isolate con-
aining this gene and the BLAST comparison of
PCR products from HLGR isolates. The size of the positive
band was 505 bp. Lanes numbered 1—7 show the presence
of this gene, whereas lane 8 represents a negative control
strain. M indicates the DNA ladder.
Table 2 Distribution of resistance to several antibiotics by species in the HLGR group.
Antibiotics E. faecalis E. faecium E. casseliﬂavus E. sulitarius
Ampicillin 19 (50%) 16 (76%) 1 (100%) 2 (100%)
Chloramphenicol 18 (47.4%) 12 (57%) 1 (100%) 2 (100%)
Ciproﬂoxacin 33 (86.5%) 20 (95.2%) 1 (100%) 2 (100%)
Erythromycin 36 (94.5%) 20 (95.2%) 1 (100%) 2 (100%)
Tetracycline 37 (94%) 15 (71.4%) 1 (100%) 2 (100%)
Vancomycin 0 10 (47.6%) 0 0
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Figure 4 Data from the sequencing and aligning of the PCR products containing the aac(6′)Ie-aph(2′′)Ia gene. Section
A shows a part of a chromatograph obtained from the above-mentioned gene sequencing. Sections B and C show the
alignment of the PCR product sequence with the M13771 st
sequence of our product. In addition, sequence 2 and the subj
this PCR product to the M13771 standard strain,
respectively. Seven isolates with MICs ranging from
64 to <256g/ml for gentamicin also carried the
aac(6′)Ie-aph(2′′)Ia gene. These data support the
Table 3 MDR patterns in of E. faecalis and E. fae-
cium belonged to HLGR group. CIP, TE, E, C and
AP indicate ciproﬂoxacin, tetracycline, erythromycin,
chloramphenicol and ampicillin, respectively.
Antibiotics E. faecalis E. faecium
CIP, TE, E, C, AP 8 (20.7%) 5 (23.8%)
CIP, TE, E, AP 5 (13%) 6 (28.5%)
CIP, TE, E, C 9 (23.6%) 2 (9.5%)
CIP, E, C, AP — 4 (19%)
TE, E, C 6 (15.7%) 2 (9.5%)
CIP, TE, AP — 1 (4.7%)
CIP, C, AP — 1 (4.7%)
CIP, TE, E 5 (13) —
TE, E 5 (13) —
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eandard strain. Sequence 1 and the query indicate the
ect indicate the result from the M13771 standard strain.
ypothesis that the presence of this gene is asso-
iated with moderate-level gentamicin resistance
n enterococci.
iscussion
he increasing number of nosocomial infections
ue to resistant Enterococcus species in healthy
ranians and their often ineffective treatments
epresent major health problems. The inherent
esistance of many pathogens to several antibi-
tics that are commonly used at hospitals and
he ability of the organisms to acquire antibiotic
esistance via mutation or conjugation have led to
ncreasing rates of resistance [11,12]. To combat
his issue, the collection of sufﬁcient information
bout the types and frequencies of antimicrobial-
esistant enterococci, including an understanding
f their glycopeptides and aminoglycosides, is
ssential.
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RLGR among clinical enterococcus strains
This study assessed the prevalence of Enterococ-
us species in an Iranian hospital. The frequencies
f E. faecium and E. faecalis isolates in our
tudy were 36% and 63%, respectively. Because of
ifferences in climate and bacterial prevalence,
he distributions of Enterococcus species differ
etween regions. Unlike countries such as India
nd Japan, where E. faecium is dominant, in Iran,
s in the USA, UK and some European countries,
. faecalis is the most common species [13].
lthough E. faecalis plays an important role in gen-
rating nosocomial infections because of its high
inding potency and its proliferation in the intes-
ine, E. faecium can more easily acquire antibiotic
esistance [14]. Hence, even a low frequency of
. faecium can have dangerous consequences. In
greement with previous studies, we isolated a high
umber of vancomycin-resistant E. faecium strains
15]; in fact, all of the vancomycin-resistant strains
e isolated were E. faecium. This result indicates
he importance of this species in distributing the
enetic ability to resist vancomycin after coloniza-
ion in the intestinal tracts of hospitalized patients
nd spreading resistance across health care centers
nd the wider community via patients and staff.
We investigated the presence of a gene respon-
ible for HLGR in the current study and observed
hat 43.7% of the examined isolates were positive
or this gene. Data from other studies in Iran con-
ucted by Emaneini et al. (52%) [16] and Feaizabadi
t al. (52%) [14] and in Kuwait (47%) [17] produced
imilar results, although the frequency of HLGR iso-
ates was found to be lower in a study conducted in
urkey (24%) [18]. The frequency of HLGR strains in
ountries located in eastern Asia is also higher, as
requencies reported from Thailand and China were
6% and 64.2%, respectively [4,10].
Numerous studies have conﬁrmed that the
ajority of HLGR phenotypes are correlated with
he expression of the aac(6′)Ie-aph(2′′)Ia gene
nd that genes such as aph(2′′)-Ib, aph(2′′)-Ic and
ph(2′′)-Id are also involved in HLGR phenotypes
10]. Previous studies in Iran have also reported that
high percentage of HLGR enterococcus strains
ith a gentamicin MIC >500g/ml contain the
ph(2′′)-Ib, aph(2′′)-Ic and aph(2′′)-Id genes [19,20].
n our study, only one of the HLGR isolates lacked
he aac(6′)Ie-aph(2′′)Ia gene, and in all but 7 iso-
ates, the presence of the gene was accompanied
y a gentamicin MIC >500g/ml. These results indi-
ate that the aac(6′)Ie-aph(2′′)Ia gene has a major
ole in creating the HLGR phenotype, both in iso-
ates from our country as well as others [14,16—18].
Irregular administration of antibiotics targeting
ensitive strains promotes the emergence of resis-
ant strains, especially MDR strains, with the ability207
o colonize the gut lumens of patients, which leads
o an increase in the direct and indirect transfer of
he genetic material of resistant strains. Recently,
igniﬁcant increases in the prevalence of resistant
nterococci with the MDR phenotype have been
eported in the USA, Europe and other developed
ountries. Our results show that the majority of
ur MDR strains were also HLGR and contained the
ac(6′)Ie-aph(2′′)Ia gene.
The high frequency of antibiotic resistance in
ur HLGR isolates as well as the high percentage
f MDR (resistance to more than three antibiotics)
an be viewed as a warning to the community
ecause the eradication and treatment of infec-
ions resulting from these resistant species is
ifﬁcult. Therefore, control and prevention meth-
ds to limit these infections are essential. Because
he aac(6′)Ie-aph(2′′)Ia gene frequently exists in
osocomial infections associated with HLGR entero-
occi, screening for this gene with molecular
echniques as well as high-dose aminoglycoside disc
ests in the laboratory may help to efﬁciently select
n appropriate protocol for antibiotic therapy and
onﬁne dangerous infections.
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